摘要
目的 评价加替沙星治疗老年社区获得性肺炎的有效性和安全性。方法以加替沙星静脉滴注为治疗组，每天400mg；头孢曲松钠静脉滴注为对照组，每天2．0g，疗程均为7～10d。对两组治疗老年社区获得性肺炎的疗效和安全性进行随机观察。结果治疗组和对照组的总有效率分别为95．33％和92．11％，细菌清除率分别为87．32％和83．33％，不良反应发生率分别为6．67％和7．24％。结论加替沙星静脉滴注治疗老年社区获得性肺炎疗效良好，不良反应少，使用安全。
Objective To evaluate the efficacy and safety of gatifloxacin in treatment of senile patients with community - acqired pneumonia（CAP）. Methods A prospective, comparative study on senile CAP patients was carried out. The patients were either intravenously given gatifloxaein 200mg twice daily （treatment group） or eeftriaxone 2.0g once daily ） the control group） for a course of 7 - 10 days. Results Clinical total effective rate in patients receiving gatifloxaein was 95.33 % and 92.11% in patients receiving eeftriaxone; the bacterial eradication rates were 87.32% in the treatment group and 83.33% in the control group, respectively. The clinical adverse effect rates were 6.67% in the treatment group and 7.24% in the control group, respectively. Conclusion Gatifloxaein is excellently effective and safe for treatment of senile CAP patients with light adverse reactions.
出处
《中国热带医学》
CAS
2006年第8期1449-1450,共2页
China Tropical Medicine
关键词
加替沙星
社区获得性肺炎
头孢曲松钠
老年
Gatifloxacin
Community - aequiredpneumonia
Ceftriaxon
The elderly
